July 15th 2025
Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
Jonathan Hirsch Discusses Challenges in Health IT Implementation
Getting Insured Could Reduce Cancer-Related Deaths Among Minorities
Dr Robert Carlson on Balancing Efficiency and Patient-Centered Care
David Fabrizio Suggests Advantages of Genomic Profiling for Payers